Oncology Nursing News®

Join us for our March LIVE webinars on metastatic colorectal cancer & hepatocellular carcinoma. In each broadcast, a pair of experts will speak LIVE on the pressing topics of diagnosis, treatment, and outcome. RSVP today to both!

Blood Cancers

FDA Grants Breakthrough Designation to Zanubrutinib for Mantle Cell Lymphoma

FDA Grants Breakthrough Designation to Zanubrutinib for Mantle Cell Lymphoma

BY GINA COLUMBUS

Axi-Cel Efficacy Persists at 2-Year Assessment for Large B-Cell Lymphoma

Axi-Cel Efficacy Persists at 2-Year Assessment for Large B-Cell Lymphoma

BY SILAS INMAN

Novel Agents, Earlier Diagnosis Driving Survival Gains in CLL

Novel Agents, Earlier Diagnosis Driving Survival Gains in CLL

BY TONY HAGEN

Next-Generation BCMA CAR T-cell Therapy Effective for Heavily Pretreated Myeloma

Next-Generation BCMA CAR T-cell Therapy Effective for Heavily Pretreated Myeloma

BY SILAS INMAN

FDA Approves Ravulizumab for Paroxysmal Nocturnal Hemoglobinuria

FDA Approves Ravulizumab for Paroxysmal Nocturnal Hemoglobinuria

BY GINA COLUMBUS

Curcumin and Vitamin D Treatment May Stabilize Disease in Patients with CLL and SLL

Curcumin and Vitamin D Treatment May Stabilize Disease in Patients with CLL and SLL

BY JESSICA SKARZYNSKI

FDA Approves Tagraxofusp-erzs for Blastic Plasmacytoid Dendritic Cell Neoplasm

FDA Approves Tagraxofusp-erzs for Blastic Plasmacytoid Dendritic Cell Neoplasm

BY KRISTIE L. KAHL

FDA Approves New Drug Regimen for Acute Lymphoblastic Leukemia

FDA Approves New Drug Regimen for Acute Lymphoblastic Leukemia

BY BRIELLE BENYON

Luspatercept Reduces Blood Transfusion Dependence in Lower-Risk MDS Anemia

Luspatercept Reduces Blood Transfusion Dependence in Lower-Risk MDS Anemia

BY KRISTIE L. KAHL

Liso-Cel Demonstrates Durable Responses in Heavily Pretreated, High-Risk CLL

Liso-Cel Demonstrates Durable Responses in Heavily Pretreated, High-Risk CLL

BY GINA COLUMBUS

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.